MAGGI ORMAND: Open Payments
NPI 1497022305 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,948 in 153 payments from 32 companies in 2025. Trend: 2023 $3,101 · 2024 $2,479 · 2025 $2,948
Food & beverage: $2,948
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $478 |
| PFIZER INC. | 26 | $469 |
| Lilly USA, LLC | 9 | $209 |
| Novo Nordisk Inc | 14 | $207 |
| Phathom Pharmaceuticals, Inc. | 4 | $164 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $137 |
| Corcept Therapeutics | 3 | $122 |
| Axsome Therapeutics, Inc. | 6 | $122 |
| GlaxoSmithKline, LLC. | 6 | $121 |
| Corium, LLC | 9 | $117 |
Products named: VRAYLAR, REXULTI, NURTEC ODT, ELIQUIS, VOQUEZNA, JARDIANCE, QULIPTA, Ozempic.
Industry payments across NC — which companies pay providers there.
